51
|
Aaij R, Abellan Beteta C, Adeva B, Adinolfi M, Adrover C, Affolder A, Ajaltouni Z, Albrecht J, Alessio F, Alexander M, Alkhazov G, Alvarez Cartelle P, Alves AA, Amato S, Amhis Y, Anderson J, Appleby RB, Aquines Gutierrez O, Archilli F, Arrabito L, Artamonov A, Artuso M, Aslanides E, Auriemma G, Bachmann S, Back JJ, Bailey DS, Balagura V, Baldini W, Barlow RJ, Barschel C, Barsuk S, Barter W, Bates A, Bauer C, Bauer T, Bay A, Bediaga I, Belogurov S, Belous K, Belyaev I, Ben-Haim E, Benayoun M, Bencivenni G, Benson S, Benton J, Bernet R, Bettler MO, van Beuzekom M, Bien A, Bifani S, Bird T, Bizzeti A, Bjørnstad PM, Blake T, Blanc F, Blanks C, Blouw J, Blusk S, Bobrov A, Bocci V, Bondar A, Bondar N, Bonivento W, Borghi S, Borgia A, Bowcock TJV, Bozzi C, Brambach T, van den Brand J, Bressieux J, Brett D, Britsch M, Britton T, Brook NH, Brown H, Büchler-Germann A, Burducea I, Bursche A, Buytaert J, Cadeddu S, Callot O, Calvi M, Calvo Gomez M, Camboni A, Campana P, Carbone A, Carboni G, Cardinale R, Cardini A, Carson L, Carvalho Akiba K, Casse G, Cattaneo M, Cauet C, Charles M, Charpentier P, Chiapolini N, Ciba K, Cid Vidal X, Ciezarek G, Clarke PEL, Clemencic M, Cliff HV, Closier J, Coca C, Coco V, Cogan J, Collins P, Comerma-Montells A, Constantin F, Contu A, Cook A, Coombes M, Corti G, Cowan GA, Currie R, D'Ambrosio C, David P, David PNY, De Bonis I, De Capua S, De Cian M, De Lorenzi F, De Miranda JM, De Paula L, De Simone P, Decamp D, Deckenhoff M, Degaudenzi H, Del Buono L, Deplano C, Derkach D, Deschamps O, Dettori F, Dickens J, Dijkstra H, Diniz Batista P, Domingo Bonal F, Donleavy S, Dordei F, Dosil Suárez A, Dossett D, Dovbnya A, Dupertuis F, Dzhelyadin R, Dziurda A, Easo S, Egede U, Egorychev V, Eidelman S, van Eijk D, Eisele F, Eisenhardt S, Ekelhof R, Eklund L, Elsasser C, Elsby D, Esperante Pereira D, Estève L, Falabella A, Fanchini E, Färber C, Fardell G, Farinelli C, Farry S, Fave V, Fernandez Albor V, Ferro-Luzzi M, Filippov S, Fitzpatrick C, Fontana M, Fontanelli F, Forty R, Frank M, Frei C, Frosini M, Furcas S, Gallas Torreira A, Galli D, Gandelman M, Gandini P, Gao Y, Garnier JC, Garofoli J, Garra Tico J, Garrido L, Gascon D, Gaspar C, Gauvin N, Gersabeck M, Gershon T, Ghez P, Gibson V, Gligorov VV, Göbel C, Golubkov D, Golutvin A, Gomes A, Gordon H, Grabalosa Gándara M, Graciani Diaz R, Granado Cardoso LA, Graugés E, Graziani G, Grecu A, Greening E, Gregson S, Gui B, Gushchin E, Guz Y, Gys T, Haefeli G, Haen C, Haines SC, Hampson T, Hansmann-Menzemer S, Harji R, Harnew N, Harrison J, Harrison PF, Hartmann T, He J, Heijne V, Hennessy K, Henrard P, Hernando Morata JA, van Herwijnen E, Hicks E, Holubyev K, Hopchev P, Hulsbergen W, Hunt P, Huse T, Huston RS, Hutchcroft D, Hynds D, Iakovenko V, Ilten P, Imong J, Jacobsson R, Jaeger A, Jahjah Hussein M, Jans E, Jansen F, Jaton P, Jean-Marie B, Jing F, John M, Johnson D, Jones CR, Jost B, Kaballo M, Kandybei S, Karacson M, Karbach TM, Keaveney J, Kenyon IR, Kerzel U, Ketel T, Keune A, Khanji B, Kim YM, Knecht M, Koopman R, Koppenburg P, Kozlinskiy A, Kravchuk L, Kreplin K, Kreps M, Krocker G, Krokovny P, Kruse F, Kruzelecki K, Kucharczyk M, Kvaratskheliya T, La Thi VN, Lacarrere D, Lafferty G, Lai A, Lambert D, Lambert RW, Lanciotti E, Lanfranchi G, Langenbruch C, Latham T, Lazzeroni C, Le Gac R, van Leerdam J, Lees JP, Lefèvre R, Leflat A, Lefrançois J, Leroy O, Lesiak T, Li L, Li Gioi L, Lieng M, Liles M, Lindner R, Linn C, Liu B, Liu G, von Loeben J, Lopes JH, Lopez Asamar E, Lopez-March N, Lu H, Luisier J, Mac Raighne A, Machefert F, Machikhiliyan IV, Maciuc F, Maev O, Magnin J, Malde S, Mamunur RMD, Manca G, Mancinelli G, Mangiafave N, Marconi U, Märki R, Marks J, Martellotti G, Martens A, Martin L, Martín Sánchez A, Martinez Santos D, Massafferri A, Mathe Z, Matteuzzi C, Matveev M, Maurice E, Maynard B, Mazurov A, McGregor G, McNulty R, Meissner M, Merk M, Merkel J, Messi R, Miglioranzi S, Milanes DA, Minard MN, Molina Rodriguez J, Monteil S, Moran D, Morawski P, Mountain R, Mous I, Muheim F, Müller K, Muresan R, Muryn B, Muster B, Musy M, Mylroie-Smith J, Naik P, Nakada T, Nandakumar R, Nasteva I, Nedos M, Needham M, Neufeld N, Nguyen-Mau C, Nicol M, Niess V, Nikitin N, Nomerotski A, Novoselov A, Oblakowska-Mucha A, Obraztsov V, Oggero S, Ogilvy S, Okhrimenko O, Oldeman R, Orlandea M, Otalora Goicochea JM, Owen P, Pal K, Palacios J, Palano A, Palutan M, Panman J, Papanestis A, Pappagallo M, Parkes C, Parkinson CJ, Passaleva G, Patel GD, Patel M, Paterson SK, Patrick GN, Patrignani C, Pavel-Nicorescu C, Pazos Alvarez A, Pellegrino A, Penso G, Pepe Altarelli M, Perazzini S, Perego DL, Perez Trigo E, Pérez-Calero Yzquierdo A, Perret P, Perrin-Terrin M, Pessina G, Petrella A, Petrolini A, Phan A, Picatoste Olloqui E, Pie Valls B, Pietrzyk B, Pilař T, Pinci D, Plackett R, Playfer S, Plo Casasus M, Polok G, Poluektov A, Polycarpo E, Popov D, Popovici B, Potterat C, Powell A, Prisciandaro J, Pugatch V, Navarro AP, Qian W, Rademacker JH, Rakotomiaramanana B, Rangel MS, Raniuk I, Raven G, Redford S, Reid MM, dos Reis AC, Ricciardi S, Rinnert K, Roa Romero DA, Robbe P, Rodrigues E, Rodrigues F, Rodriguez Perez P, Rogers GJ, Roiser S, Romanovsky V, Rosello M, Rouvinet J, Ruf T, Ruiz H, Sabatino G, Saborido Silva JJ, Sagidova N, Sail P, Saitta B, Salzmann C, Sannino M, Santacesaria R, Santamarina Rios C, Santinelli R, Santovetti E, Sapunov M, Sarti A, Satriano C, Satta A, Savrie M, Savrina D, Schaack P, Schiller M, Schleich S, Schlupp M, Schmelling M, Schmidt B, Schneider O, Schopper A, Schune MH, Schwemmer R, Sciascia B, Sciubba A, Seco M, Semennikov A, Senderowska K, Sepp I, Serra N, Serrano J, Seyfert P, Shapkin M, Shapoval I, Shatalov P, Shcheglov Y, Shears T, Shekhtman L, Shevchenko O, Shevchenko V, Shires A, Silva Coutinho R, Skwarnicki T, Smith AC, Smith NA, Smith E, Sobczak K, Soler FJP, Solomin A, Soomro F, Souza De Paula B, Spaan B, Sparkes A, Spradlin P, Stagni F, Stahl S, Steinkamp O, Stoica S, Stone S, Storaci B, Straticiuc M, Straumann U, Subbiah VK, Swientek S, Szczekowski M, Szczypka P, Szumlak T, T'jampens S, Teodorescu E, Teubert F, Thomas C, Thomas E, van Tilburg J, Tisserand V, Tobin M, Topp-Joergensen S, Torr N, Tournefier E, Tran MT, Tsaregorodtsev A, Tuning N, Ubeda Garcia M, Ukleja A, Urquijo P, Uwer U, Vagnoni V, Valenti G, Vazquez Gomez R, Vazquez Regueiro P, Vecchi S, Velthuis JJ, Veltri M, Viaud B, Videau I, Vilasis-Cardona X, Visniakov J, Vollhardt A, Volyanskyy D, Voong D, Vorobyev A, Voss H, Wandernoth S, Wang J, Ward DR, Watson NK, Webber AD, Websdale D, Whitehead M, Wiedner D, Wiggers L, Wilkinson G, Williams MP, Williams M, Wilson FF, Wishahi J, Witek M, Witzeling W, Wotton SA, Wyllie K, Xie Y, Xing F, Xing Z, Yang Z, Young R, Yushchenko O, Zavertyaev M, Zhang F, Zhang L, Zhang WC, Zhang Y, Zhelezov A, Zhong L, Zverev E, Zvyagin A. Evidence for CP violation in time-integrated D0→h(-)h(+) decay rates. PHYSICAL REVIEW LETTERS 2012; 108:111602. [PMID: 22540460 DOI: 10.1103/physrevlett.108.111602] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/06/2011] [Indexed: 05/31/2023]
Abstract
A search for time-integrated CP violation in D(0)→h(-)h(+) (h=K, π) decays is presented using 0.62 fb(-1) of data collected by LHCb in 2011. The flavor of the charm meson is determined by the charge of the slow pion in the D(*+)→D(0)π(+) and D(*-)→D[over ¯](0)π(-) decay chains. The difference in CP asymmetry between D(0)→K(-)K(+) and D(0)→π(-)π(+), ΔA(CP)≡A(CP)(K(-)K(+))-A(CP)(π(-)π(+)), is measured to be [-0.82±0.21(stat)±0.11(syst)]%. This differs from the hypothesis of CP conservation by 3.5 standard deviations.
Collapse
|
52
|
Aaij R, Abellan Beteta C, Adeva B, Adinolfi M, Adrover C, Affolder A, Ajaltouni Z, Albrecht J, Alessio F, Alexander M, Alkhazov G, Alvarez Cartelle P, Alves AA, Amato S, Amhis Y, Anderson J, Appleby RB, Aquines Gutierrez O, Archilli F, Arrabito L, Artamonov A, Artuso M, Aslanides E, Auriemma G, Bachmann S, Back JJ, Bailey DS, Balagura V, Baldini W, Barlow RJ, Barschel C, Barsuk S, Barter W, Bates A, Bauer C, Bauer T, Bay A, Bediaga I, Belous K, Belyaev I, Ben-Haim E, Benayoun M, Bencivenni G, Benson S, Benton J, Bernet R, Bettler MO, van Beuzekom M, Bien A, Bifani S, Bizzeti A, Bjørnstad PM, Blake T, Blanc F, Blanks C, Blouw J, Blusk S, Bobrov A, Bocci V, Bondar A, Bondar N, Bonivento W, Borghi S, Borgia A, Bowcock TJV, Bozzi C, Brambach T, van den Brand J, Bressieux J, Brett D, Brisbane S, Britsch M, Britton T, Brook NH, Brown H, Büchler-Germann A, Burducea I, Bursche A, Buytaert J, Cadeddu S, Caicedo Carvajal JM, Callot O, Calvi M, Calvo Gomez M, Camboni A, Campana P, Carbone A, Carboni G, Cardinale R, Cardini A, Carson L, Carvalho Akiba K, Casse G, Cattaneo M, Charles M, Charpentier P, Chiapolini N, Ciba K, Cid Vidal X, Ciezarek G, Clarke PEL, Clemencic M, Cliff HV, Closier J, Coca C, Coco V, Cogan J, Collins P, Comerma-Montells A, Constantin F, Conti G, Contu A, Cook A, Coombes M, Corti G, Cowan GA, Currie R, D'Almagne B, D'Ambrosio C, David P, De Bonis I, De Capua S, De Cian M, De Lorenzi F, De Miranda JM, De Paula L, De Simone P, Decamp D, Deckenhoff M, Degaudenzi H, Deissenroth M, Del Buono L, Deplano C, Deschamps O, Dettori F, Dickens J, Dijkstra H, Diniz Batista P, Domingo Bonal F, Donleavy S, Dosil Suárez A, Dossett D, Dovbnya A, Dupertuis F, Dzhelyadin R, Easo S, Egede U, Egorychev V, Eidelman S, van Eijk D, Eisele F, Eisenhardt S, Ekelhof R, Eklund L, Elsasser C, d'Enterria DG, Esperante Pereira D, Estève L, Falabella A, Fanchini E, Färber C, Fardell G, Farinelli C, Farry S, Fave V, Fernandez Albor V, Ferro-Luzzi M, Filippov S, Fitzpatrick C, Fontana M, Fontanelli F, Forty R, Frank M, Frei C, Frosini M, Furcas S, Gallas Torreira A, Galli D, Gandelman M, Gandini P, Gao Y, Garnier JC, Garofoli J, Garra Tico J, Garrido L, Gascon D, Gaspar C, Gauvin N, Gersabeck M, Gershon T, Ghez P, Gibson V, Gligorov VV, Göbel C, Golubkov D, Golutvin A, Gomes A, Gordon H, Grabalosa Gándara M, Graciani Diaz R, Granado Cardoso LA, Graugés E, Graziani G, Grecu A, Greening E, Gregson S, Gui B, Gushchin E, Guz Y, Gys T, Haefeli G, Haen C, Haines SC, Hampson T, Hansmann-Menzemer S, Harji R, Harnew N, Harrison J, Harrison PF, He J, Heijne V, Hennessy K, Henrard P, Hernando Morata JA, van Herwijnen E, Hicks E, Hofmann W, Holubyev K, Hopchev P, Hulsbergen W, Hunt P, Huse T, Huston RS, Hutchcroft D, Hynds D, Iakovenko V, Ilten P, Imong J, Jacobsson R, Jaeger A, Jahjah Hussein M, Jans E, Jansen F, Jaton P, Jean-Marie B, Jing F, John M, Johnson D, Jones CR, Jost B, Kandybei S, Karacson M, Karbach TM, Keaveney J, Kerzel U, Ketel T, Keune A, Khanji B, Kim YM, Knecht M, Koblitz S, Koppenburg P, Kozlinskiy A, Kravchuk L, Kreplin K, Kreps M, Krocker G, Krokovny P, Kruse F, Kruzelecki K, Kucharczyk M, Kukulak S, Kumar R, Kvaratskheliya T, La Thi VN, Lacarrere D, Lafferty G, Lai A, Lambert D, Lambert RW, Lanciotti E, Lanfranchi G, Langenbruch C, Latham T, Le Gac R, van Leerdam J, Lees JP, Lefèvre R, Leflat A, Lefrançois J, Leroy O, Lesiak T, Li L, Li Gioi L, Lieng M, Liles M, Lindner R, Linn C, Liu B, Liu G, Lopes JH, Lopez Asamar E, Lopez-March N, Luisier J, Machefert F, Machikhiliyan IV, Maciuc F, Maev O, Magnin J, Malde S, Mamunur RMD, Manca G, Mancinelli G, Mangiafave N, Marconi U, Märki R, Marks J, Martellotti G, Martens A, Martin L, Martín Sánchez A, Martinez Santos D, Massafferri A, Mathe Z, Matteuzzi C, Matveev M, Maurice E, Maynard B, Mazurov A, McGregor G, McNulty R, McLean C, Meissner M, Merk M, Merkel J, Messi R, Miglioranzi S, Milanes DA, Minard MN, Monteil S, Moran D, Morawski P, Mountain R, Mous I, Muheim F, Müller K, Muresan R, Muryn B, Musy M, Mylroie-Smith J, Naik P, Nakada T, Nandakumar R, Nardulli J, Nasteva I, Nedos M, Needham M, Neufeld N, Nguyen-Mau C, Nicol M, Nies S, Niess V, Nikitin N, Nomerotski A, Oblakowska-Mucha A, Obraztsov V, Oggero S, Ogilvy S, Okhrimenko O, Oldeman R, Orlandea M, Otalora Goicochea JM, Owen P, Pal K, Palacios J, Palano A, Palutan M, Panman J, Papanestis A, Pappagallo M, Parkes C, Parkinson CJ, Passaleva G, Patel GD, Patel M, Paterson SK, Patrick GN, Patrignani C, Pavel-Nicorescu C, Pazos Alvarez A, Pellegrino A, Penso G, Pepe Altarelli M, Perazzini S, Perego DL, Perez Trigo E, Pérez-Calero Yzquierdo A, Perret P, Perrin-Terrin M, Pessina G, Petrella A, Petrolini A, Picatoste Olloqui E, Pie Valls B, Pietrzyk B, Pilar T, Pinci D, Plackett R, Playfer S, Plo Casasus M, Polok G, Poluektov A, Polycarpo E, Popov D, Popovici B, Potterat C, Powell A, du Pree T, Prisciandaro J, Pugatch V, Puig Navarro A, Qian W, Rademacker JH, Rakotomiaramanana B, Rangel MS, Raniuk I, Raven G, Redford S, Reid MM, dos Reis AC, Ricciardi S, Rinnert K, Roa Romero DA, Robbe P, Rodrigues E, Rodrigues F, Rodriguez Perez P, Rogers GJ, Roiser S, Romanovsky V, Rosello M, Rouvinet J, Ruf T, Ruiz H, Sabatino G, Saborido Silva JJ, Sagidova N, Sail P, Saitta B, Salzmann C, Sannino M, Santacesaria R, Santinelli R, Santovetti E, Sapunov M, Sarti A, Satriano C, Satta A, Savrie M, Savrina D, Schaack P, Schiller M, Schleich S, Schmelling M, Schmidt B, Schneider O, Schopper A, Schune MH, Schwemmer R, Sciascia B, Sciubba A, Seco M, Semennikov A, Senderowska K, Sepp I, Serra N, Serrano J, Seyfert P, Shao B, Shapkin M, Shapoval I, Shatalov P, Shcheglov Y, Shears T, Shekhtman L, Shevchenko O, Shevchenko V, Shires A, Silva Coutinho R, Skottowe HP, Skwarnicki T, Smith AC, Smith NA, Smith E, Sobczak K, Soler FJP, Solomin A, Soomro F, Souza De Paula B, Spaan B, Sparkes A, Spradlin P, Stagni F, Stahl S, Steinkamp O, Stoica S, Stone S, Storaci B, Straticiuc M, Straumann U, Styles N, Subbiah VK, Swientek S, Szczekowski M, Szczypka P, Szumlak T, T'Jampens S, Teodorescu E, Teubert F, Thomas C, Thomas E, van Tilburg J, Tisserand V, Tobin M, Topp-Joergensen S, Torr N, Tran MT, Tsaregorodtsev A, Tuning N, Ukleja A, Urquijo P, Uwer U, Vagnoni V, Valenti G, Vazquez Gomez R, Vazquez Regueiro P, Vecchi S, Velthuis JJ, Veltri M, Vervink K, Viaud B, Videau I, Vilasis-Cardona X, Visniakov J, Vollhardt A, Voong D, Vorobyev A, Voss H, Wacker K, Wandernoth S, Wang J, Ward DR, Webber AD, Websdale D, Whitehead M, Wiedner D, Wiggers L, Wilkinson G, Williams MP, Williams M, Wilson FF, Wishahi J, Witek M, Witzeling W, Wotton SA, Wyllie K, Xie Y, Xing F, Xing Z, Yang Z, Young R, Yushchenko O, Zavertyaev M, Zhang L, Zhang WC, Zhang Y, Zhelezov A, Zhong L, Zverev E, Zvyagin A. Search for lepton number violating decays B+ → π- μ+ μ+ and B+ → K- μ+ μ+. PHYSICAL REVIEW LETTERS 2012; 108:101601. [PMID: 22463398 DOI: 10.1103/physrevlett.108.101601] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/11/2011] [Indexed: 05/31/2023]
Abstract
A search is performed for the lepton number violating decay B+ → h- μ+ μ+, where h- represents a K- or a π-, using an integrated luminosity of 36 pb(-1) of data collected with the LHCb detector. The decay is forbidden in the standard model but allowed in models with a Majorana neutrino. No signal is observed in either channel and limits of B(B+ → K- μ+ μ+) < 5.4×10(-8) and B(B+ → π- μ+ μ+) < 5.8×10(-8) are set at the 95% confidence level. These improve the previous best limits by factors of 40 and 30, respectively.
Collapse
|
53
|
Aaij R, Abellan Beteta C, Adeva B, Adinolfi M, Adrover C, Affolder A, Ajaltouni Z, Albrecht J, Alessio F, Alexander M, Alkhazov G, Alvarez Cartelle P, Alves AA, Amato S, Amhis Y, Anderson J, Appleby RB, Aquines Gutierrez O, Archilli F, Arrabito L, Artamonov A, Artuso M, Aslanides E, Auriemma G, Bachmann S, Back JJ, Bailey DS, Balagura V, Baldini W, Barlow RJ, Barschel C, Barsuk S, Barter W, Bates A, Bauer C, Bauer T, Bay A, Bediaga I, Belogurov S, Belous K, Belyaev I, Ben-Haim E, Benayoun M, Bencivenni G, Benson S, Benton J, Bernet R, Bettler MO, van Beuzekom M, Bien A, Bifani S, Bird T, Bizzeti A, Bjørnstad PM, Blake T, Blanc F, Blanks C, Blouw J, Blusk S, Bobrov A, Bocci V, Bondar A, Bondar N, Bonivento W, Borghi S, Borgia A, Bowcock TJV, Bozzi C, Brambach T, van den Brand J, Bressieux J, Brett D, Britsch M, Britton T, Brook NH, Brown H, Büchler-Germann A, Burducea I, Bursche A, Buytaert J, Cadeddu S, Callot O, Calvi M, Calvo Gomez M, Camboni A, Campana P, Carbone A, Carboni G, Cardinale R, Cardini A, Carson L, Carvalho Akiba K, Casse G, Cattaneo M, Cauet C, Charles M, Charpentier P, Chiapolini N, Ciba K, Cid Vidal X, Ciezarek G, Clarke PEL, Clemencic M, Cliff HV, Closier J, Coca C, Coco V, Cogan J, Collins P, Comerma-Montells A, Constantin F, Contu A, Cook A, Coombes M, Corti G, Cowan GA, Currie R, D'Ambrosio C, David P, David PNY, De Bonis I, De Capua S, De Cian M, De Lorenzi F, De Miranda JM, De Paula L, De Simone P, Decamp D, Deckenhoff M, Degaudenzi H, Del Buono L, Deplano C, Derkach D, Deschamps O, Dettori F, Dickens J, Dijkstra H, Diniz Batista P, Bonal F, Domingo Donleavy S, Dordei F, Dosil Suárez A, Dossett D, Dovbnya A, Dupertuis F, Dzhelyadin R, Dziurda A, Easo S, Egede U, Egorychev V, Eidelman S, van Eijk D, Eisele F, Eisenhardt S, Ekelhof R, Eklund L, Elsasser C, Elsby D, Esperante Pereira D, Estève L, Falabella A, Fanchini E, Färber C, Fardell G, Farinelli C, Farry S, Fave V, Fernandez Albor V, Ferro-Luzzi M, Filippov S, Fitzpatrick C, Fontana M, Fontanelli F, Forty R, Frank M, Frei C, Frosini M, Furcas S, Gallas Torreira A, Galli D, Gandelman M, Gandini P, Gao Y, Garnier JC, Garofoli J, Garra Tico J, Garrido L, Gascon D, Gaspar C, Gauvin N, Gersabeck M, Gershon T, Ghez P, Gibson V, Gligorov VV, Göbel C, Golubkov D, Golutvin A, Gomes A, Gordon H, Grabalosa Gándara M, Graciani Diaz R, Granado Cardoso LA, Graugés E, Graziani G, Grecu A, Greening E, Gregson S, Gui B, Gushchin E, Guz Y, Gys T, Haefeli G, Haen C, Haines SC, Hampson T, Hansmann-Menzemer S, Harji R, Harnew N, Harrison J, Harrison PF, Hartmann T, He J, Heijne V, Hennessy K, Henrard P, Hernando Morata JA, van Herwijnen E, Hicks E, Holubyev K, Hopchev P, Hulsbergen W, Hunt P, Huse T, Huston RS, Hutchcroft D, Hynds D, Iakovenko V, Ilten P, Imong J, Jacobsson R, Jaeger A, Jahjah Hussein M, Jans E, Jansen F, Jaton P, Jean-Marie B, Jing F, John M, Johnson D, Jones CR, Jost B, Kaballo M, Kandybei S, Karacson M, Karbach TM, Keaveney J, Kenyon IR, Kerzel U, Ketel T, Keune A, Khanji B, Kim YM, Knecht M, Koppenburg P, Kozlinskiy A, Kravchuk L, Kreplin K, Kreps M, Krocker G, Krokovny P, Kruse F, Kruzelecki K, Kucharczyk M, Kvaratskheliya T, La Thi VN, Lacarrere D, Lafferty G, Lai A, Lambert D, Lambert RW, Lanciotti E, Lanfranchi G, Langenbruch C, Latham T, Lazzeroni C, Le Gac R, van Leerdam J, Lees JP, Lefèvre R, Leflat A, Lefrançois J, Leroy O, Lesiak T, Li L, Li Gioi L, Lieng M, Liles M, Lindner R, Linn C, Liu B, Liu G, von Loeben J, Lopes JH, Lopez Asamar E, Lopez-March N, Lu H, Luisier J, Mac Raighne A, Machefert F, Machikhiliyan IV, Maciuc F, Maev O, Magnin J, Malde S, Mamunur RMD, Manca G, Mancinelli G, Mangiafave N, Marconi U, Märki R, Marks J, Martellotti G, Martens A, Martin L, Martín Sánchez A, Martinez Santos D, Massafferri A, Mathe Z, Matteuzzi C, Matveev M, Maurice E, Maynard B, Mazurov A, McGregor G, McNulty R, Meissner M, Merk M, Merkel J, Messi R, Miglioranzi S, Milanes DA, Minard MN, Molina Rodriguez J, Monteil S, Moran D, Morawski P, Mountain R, Mous I, Muheim F, Müller K, Muresan R, Muryn B, Muster B, Musy M, Mylroie-Smith J, Naik P, Nakada T, Nandakumar R, Nasteva I, Nedos M, Needham M, Neufeld N, Nguyen-Mau C, Nicol M, Niess V, Nikitin N, Nomerotski A, Novoselov A, Oblakowska-Mucha A, Obraztsov V, Oggero S, Ogilvy S, Okhrimenko O, Oldeman R, Orlandea M, Otalora Goicochea JM, Owen P, Pal K, Palacios J, Palano A, Palutan M, Panman J, Papanestis A, Pappagallo M, Parkes C, Parkinson CJ, Passaleva G, Patel GD, Patel M, Paterson SK, Patrick GN, Patrignani C, Pavel-Nicorescu C, Pazos Alvarez A, Pellegrino A, Penso G, Pepe Altarelli M, Perazzini S, Perego DL, Perez Trigo E, Pérez-Calero Yzquierdo A, Perret P, Perrin-Terrin M, Pessina G, Petrella A, Petrolini A, Phan A, Picatoste Olloqui E, Pie Valls B, Pietrzyk B, Pilař T, Pinci D, Plackett R, Playfer S, Plo Casasus M, Polok G, Poluektov A, Polycarpo E, Popov D, Popovici B, Potterat C, Powell A, Prisciandaro J, Pugatch V, Puig Navarro A, Qian W, Rademacker JH, Rakotomiaramanana B, Rangel MS, Raniuk I, Raven G, Redford S, Reid MM, dos Reis AC, Ricciardi S, Rinnert K, Roa Romero DA, Robbe P, Rodrigues E, Rodrigues F, Rodriguez Perez P, Rogers GJ, Roiser S, Romanovsky V, Rosello M, Rouvinet J, Ruf T, Ruiz H, Sabatino G, Saborido Silva JJ, Sagidova N, Sail P, Saitta B, Salzmann C, Sannino M, Santacesaria R, Santamarina Rios C, Santinelli R, Santovetti E, Sapunov M, Sarti A, Satriano C, Satta A, Savrie M, Savrina D, Schaack P, Schiller M, Schleich S, Schlupp M, Schmelling M, Schmidt B, Schneider O, Schopper A, Schune MH, Schwemmer R, Sciascia B, Sciubba A, Seco M, Semennikov A, Senderowska K, Sepp I, Serra N, Serrano J, Seyfert P, Shapkin M, Shapoval I, Shatalov P, Shcheglov Y, Shears T, Shekhtman L, Shevchenko O, Shevchenko V, Shires A, Silva Coutinho R, Skwarnicki T, Smith AC, Smith NA, Smith E, Sobczak K, Soler FJP, Solomin A, Soomro F, Souza De Paula B, Spaan B, Sparkes A, Spradlin P, Stagni F, Stahl S, Steinkamp O, Stoica S, Stone S, Storaci B, Straticiuc M, Straumann U, Subbiah VK, Swientek S, Szczekowski M, Szczypka P, Szumlak T, T'Jampens S, Teodorescu E, Teubert F, Thomas C, Thomas E, van Tilburg J, Tisserand V, Tobin M, Topp-Joergensen S, Torr N, Tournefier E, Tran MT, Tsaregorodtsev A, Tuning N, Ubeda Garcia M, Ukleja A, Urquijo P, Uwer U, Vagnoni V, Valenti G, Vazquez Gomez R, Vazquez Regueiro P, Vecchi S, Velthuis JJ, Veltri M, Viaud B, Videau I, Vilasis-Cardona X, Visniakov J, Vollhardt A, Volyanskyy D, Voong D, Vorobyev A, Voss H, Wandernoth S, Wang J, Ward DR, Watson NK, Webber AD, Websdale D, Whitehead M, Wiedner D, Wiggers L, Wilkinson G, Williams MP, Williams M, Wilson FF, Wishahi J, Witek M, Witzeling W, Wotton SA, Wyllie K, Xie Y, Xing F, Xing Z, Yang Z, Young R, Yushchenko O, Zavertyaev M, Zhang F, Zhang L, Zhang WC, Zhang Y, Zhelezov A, Zhong L, Zverev E, Zvyagin A. Measurement of the CP-violating phase ϕ(s) in the decay B(s)(0) → J/ψϕ. PHYSICAL REVIEW LETTERS 2012; 108:101803. [PMID: 22463401 DOI: 10.1103/physrevlett.108.101803] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/14/2011] [Indexed: 05/31/2023]
Abstract
We present a measurement of the time-dependent CP-violating asymmetry in B(s)(0) → J/ψϕ decays, using data collected with the LHCb detector at the LHC. The decay time distribution of B(s)(0) → J/ψϕ is characterized by the decay widths Γ(H) and Γ(L) of the heavy and light mass eigenstates, respectively, of the B(s)(0) - B(s)(0) system and by a CP-violating phase ϕ(s). In a sample of about 8500 B(s)(0) → J/ψϕ events isolated from 0.37 fb(-1) of pp collisions at sqrt[s] = 7 TeV, we measure ϕ(s) = 0.15 ± 0.18(stat) ± 0.06(syst) rad. We also find an average B(s)(0) decay width Γ(s) ≡ (Γ(L) + Γ(H))/2 = 0.657 ± 0.009(stat) ± 0.008(syst) ps(-1) and a decay width difference ΔΓ(s) ≡ Γ(L) - Γ(H) = 0.123 ± 0.029(stat) ± 0.011(syst) ps(-1). Our measurement is insensitive to the transformation (ϕ(s),ΔΓ(s)) ↦ (π - ϕ(s), -ΔΓ(s)).
Collapse
|
54
|
Kim HS, Kim DK, Kim AR, Mun SH, Lee SK, Kim JH, Kim YM, Choi WS. Fyn positively regulates the activation of DAP12 and FcRγ-mediated costimulatory signals by RANKL during osteoclastogenesis. Cell Signal 2012; 24:1306-14. [PMID: 22387224 DOI: 10.1016/j.cellsig.2012.02.014] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2012] [Accepted: 02/19/2012] [Indexed: 12/26/2022]
Abstract
Osteoclasts (OCs) are the only bone-resorbing cells and are critically involved in various bone-associated diseases, including osteoporosis and rheumatoid arthritis. Differentiation of OCs from bone marrow macrophage cells (BMMs) is regulated by RANK and the adaptor protein (DAP12/FcRγ)-mediated costimulatory signals. However, it is unknown how RANKL/RANK signal stimulates phosphorylation of DAP12/FcRγ to initiate the costimulatory signals. As reported here, we found that OC differentiation and acquisition of bone resorption capacity were suppressed in RANKL-stimulated Fyn(-/-) or Fyn-siRNA-transfected BMMs, but could be restored by overexpression of Fyn kinase in Fyn(-/-) BMMs. However, the RANKL-stimulated proliferation of BMMs was unaffected by the absence of Fyn. In addition, RANKL-stimulated Fyn(-/-) BMMs no longer exhibited the optimal induction of typical OC markers such as NFATc1, c-Fos, c-Src, TRAF6, and cathepsin K or costimulatory signals such as the activating phosphorylations of Syk, PLCγ2, and Gab2. These were restored by overexpression of Fyn in Fyn(-/-) BMMs. Immunoprecipitation studies also indicated that the adaptor proteins DAP12/FcRγ and Syk interacted with RANK during RANKL stimulation in BMMs in a Fyn-dependent manner. Phosphorylation of the DAP12/FcRγ and the recruitment of Syk by DAP12/FcRγ were suppressed in Fyn(-/-) BMMs. This is the first demonstration that Fyn relays the initial RANK/RANKL signal to the ITAM-containing adaptors DAP12/FcRγ for OC differentiation.
Collapse
|
55
|
Kim DW, Lee EJ, Jung SJ, Ryu JH, Kim YM. Role of sonographic diagnosis in managing Bethesda class III nodules. AJNR Am J Neuroradiol 2011; 32:2136-41. [PMID: 21920860 DOI: 10.3174/ajnr.a2686] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE Bethesda class III cytology is an important limitation of the US-FNA in assessing thyroid nodules. This study aimed to assess the diagnostic efficacy of US in evaluating thyroid nodules with Bethesda class III cytology. MATERIALS AND METHODS From January 2008 to December 2009, 1036 patients with 1289 thyroid nodules diagnosed by US and subsequent US-FNA biopsy were enrolled in the study. On the basis of US features, each thyroid nodule was prospectively classified by a single radiologist into 1 of 5 diagnostic categories: benign, probably benign, borderline, possibly malignant, and malignant. Solid nodules were classified by using all 5 categories, whereas partially cystic nodules were classified by using 4 (borderline was omitted). We calculated the diagnostic efficacy of thyroid US by comparing the US diagnoses with the histopathology results of Bethesda class III nodules. RESULTS Of the 51 Bethesda class III nodules, 35 were surgically confirmed and 8 were histologically diagnosed, and a malignancy rate of 46.5% (20/43) was determined. From the 43 nodules, the sensitivity, specificity, positive and negative predictive values, and accuracy were calculated with 9 borderline nodules excluded (100%, 94.7%, 93.3%, 100%, and 97.0%, respectively) and with the 9 when reclassified as benign (63.6%, 95.2%, 93.3%, 71.4%, and 79.1%, respectively) and malignant (100%, 85.7%, 88.0%, 100%, and 93.0%, respectively). The values obtained with exclusion and malignancy reclassification of 9 borderline nodules were not significantly different (P = .250). CONCLUSIONS US diagnosis by using the present US classification system can be helpful for managing Bethesda class III nodules.
Collapse
|
56
|
Aaij R, Adeva B, Adinolfi M, Adrover C, Affolder A, Ajaltouni Z, Albrecht J, Alessio F, Alexander M, Alkhazov G, Alvarez Cartelle P, Alves AA, Amato S, Amhis Y, Amoraal J, Anderson J, Appleby RB, Gutierrez OA, Arrabito L, Artamonov A, Artuso M, Aslanides E, Auriemma G, Bachmann S, Back JJ, Bailey DS, Balagura V, Baldini W, Barlow RJ, Barschel C, Barsuk S, Barter W, Bates A, Bauer C, Bauer T, Bay A, Bediaga I, Belous K, Belyaev I, Ben-Haim E, Benayoun M, Bencivenni G, Benson S, Benton J, Bernet R, Bettler MO, van Beuzekom M, Bien A, Bifani S, Bizzeti A, Bjørnstad PM, Blake T, Blanc F, Blanks C, Blouw J, Blusk S, Bobrov A, Bocci V, Bondar A, Bondar N, Bonivento W, Borghi S, Borgia A, Bowcock TJV, Bozzi C, Brambach T, van den Brand J, Bressieux J, Brisbane S, Britsch M, Britton T, Brook NH, Büchler-Germann A, Bursche A, Buytaert J, Cadeddu S, Carvajal JMC, Callot O, Calvi M, Gomez MC, Camboni A, Campana P, Carbone A, Carboni G, Cardinale R, Cardini A, Carson L, Akiba KC, Casse G, Cattaneo M, Charles M, Charpentier P, Chiapolini N, Vidal XC, Clarke PEL, Clemencic M, Cliff HV, Closier J, Coca C, Coco V, Cogan J, Collins P, Constantin F, Conti G, Contu A, Cook A, Coombes M, Corti G, Cowan GA, Currie R, D'Almagne B, D'Ambrosio C, David P, David PNY, De Bonis I, De Capua S, De Cian M, De Lorenzi F, De Miranda JM, De Paula L, De Simone P, Decamp D, Deckenhoff M, Degaudenzi H, Deissenroth M, Del Buono L, Deplano C, Deschamps O, Dettori F, Dickens J, Dijkstra H, Batista PD, Dossett D, Dovbnya A, Dupertuis F, Dzhelyadin R, Eames C, Easo S, Egede U, Egorychev V, Eidelman S, van Eijk D, Eisele F, Eisenhardt S, Ekelhof R, Eklund L, Elsasser C, d'Enterria DG, Pereira DE, Estève L, Falabella A, Fanchini E, Färber C, Fardell G, Farinelli C, Farry S, Fave V, Albor VF, Ferro-Luzzi M, Filippov S, Fitzpatrick C, Fontana M, Fontanelli F, Forty R, Frank M, Frei C, Frosini M, Furcas S, Torreira AG, Galli D, Gandelman M, Gandini P, Gao Y, Garnier JC, Garofoli J, Garrido L, Gaspar C, Gauvin N, Gersabeck M, Gershon T, Ghez P, Gibson V, Gligorov VV, Göbel C, Golubkov D, Golutvin A, Gomes A, Gordon H, Gándara MG, Diaz RG, Cardoso LAG, Graugés E, Graziani G, Grecu A, Gregson S, Gui B, Gushchin E, Guz Y, Gys T, Haefeli G, Haines SC, Hampson T, Hansmann-Menzemer S, Harji R, Harnew N, Harrison J, Harrison PF, He J, Heijne V, Hennessy K, Henrard P, Morata JAH, van Herwijnen E, Hofmann W, Holubyev K, Hopchev P, Hulsbergen W, Hunt P, Huse T, Huston RS, Hutchcroft D, Hynds D, Iakovenko V, Ilten P, Imong J, Jacobsson R, Hussein MJ, Jans E, Jansen F, Jaton P, Jean-Marie B, Jing F, John M, Johnson D, Jones CR, Jost B, Kandybei S, Karbach TM, Keaveney J, Kerzel U, Ketel T, Keune A, Khanji B, Kim YM, Knecht M, Koblitz S, Koppenburg P, Kozlinskiy A, Kravchuk L, Kreplin K, Krocker G, Krokovny P, Kruse F, Kruzelecki K, Kucharczyk M, Kukulak S, Kumar R, Kvaratskheliya T, La Thi VN, Lacarrere D, Lafferty G, Lai A, Lambert D, Lambert RW, Lanciotti E, Lanfranchi G, Langenbruch C, Latham T, Le Gac R, van Leerdam J, Lees JP, Lefèvre R, Leflat A, Lefrançois J, Leroy O, Lesiak T, Li L, Li YY, Li Gioi L, Lieng M, Lindner R, Linn C, Liu B, Liu G, Lopes JH, Asamar EL, Lopez-March N, Luisier J, Machefert F, Machikhiliyan IV, Maciuc F, Maev O, Magnin J, Maier A, Malde S, Mamunur RMD, Manca G, Mancinelli G, Mangiafave N, Marconi U, Märki R, Marks J, Martellotti G, Martens A, Martin L, Sánchez AM, Santos DM, Massafferri A, Mathe Z, Matteuzzi C, Matveev M, Maurice E, Maynard B, Mazurov A, McGregor G, McNulty R, Mclean C, Meissner M, Merk M, Merkel J, Messi R, Miglioranzi S, Milanes DA, Minard MN, Monteil S, Moran D, Morawski P, Morris JV, Mountain R, Mous I, Muheim F, Müller K, Muresan R, Muryn B, Musy M, Naik P, Nakada T, Nandakumar R, Nardulli J, Nedos M, Needham M, Neufeld N, Nguyen-Mau C, Nicol M, Nies S, Niess V, Nikitin N, Oblakowska-Mucha A, Obraztsov V, Oggero S, Ogilvy S, Okhrimenko O, Oldeman R, Orlandea M, Goicochea JMO, Pal B, Palacios J, Palutan M, Panman J, Papanestis A, Pappagallo M, Parkes C, Parkinson CJ, Passaleva G, Patel GD, Patel M, Paterson SK, Patrick GN, Patrignani C, Pavel-Nicorescu C, Alvarez AP, Pellegrino A, Penso G, Altarelli MP, Perazzini S, Perego DL, Trigo EP, Yzquierdo APC, Perret P, Perrin-Terrin M, Pessina G, Petrella A, Petrolini A, Pie Valls B, Pietrzyk B, Pilar T, Pinci D, Plackett R, Playfer S, Plo Casasus M, Polok G, Poluektov A, Polycarpo E, Popov D, Popovici B, Potterat C, Powell A, du Pree T, Pugatch V, Navarro AP, Qian W, Rademacker JH, Rakotomiaramanana B, Raniuk I, Raven G, Redford S, Reid MM, dos Reis AC, Ricciardi S, Rinnert K, Roa Romero DA, Robbe P, Rodrigues E, Rodrigues F, Cobo CR, Perez PR, Rogers GJ, Romanovsky V, Rouvinet J, Ruf T, Ruiz H, Sabatino G, Silva JJS, Sagidova N, Sail P, Saitta B, Salzmann C, Sannino M, Santacesaria R, Santinelli R, Santovetti E, Sapunov M, Sarti A, Satriano C, Satta A, Savrie M, Savrina D, Schaack P, Schiller M, Schleich S, Schmelling M, Schmidt B, Schneider O, Schopper A, Schune MH, Schwemmer R, Sciubba A, Seco M, Semennikov A, Senderowska K, Serra N, Serrano J, Seyfert P, Shao B, Shapkin M, Shapoval I, Shatalov P, Shcheglov Y, Shears T, Shekhtman L, Shevchenko O, Shevchenko V, Shires A, Coutinho RS, Skottowe HP, Skwarnicki T, Smith AC, Smith NA, Sobczak K, Soler FJP, Solomin A, Soomro F, Souza De Paula B, Spaan B, Sparkes A, Spradlin P, Stagni F, Stahl S, Steinkamp O, Stoica S, Stone S, Storaci B, Straumann U, Styles N, Swientek S, Szczekowski M, Szczypka P, Szumlak T, T'jampens S, Teodorescu E, Teubert F, Thomas C, Thomas E, van Tilburg J, Tisserand V, Tobin M, Topp-Joergensen S, Tran MT, Tsaregorodtsev A, Tuning N, Ukleja A, Urquijo P, Uwer U, Vagnoni V, Valenti G, Gomez RV, Regueiro PV, Vecchi S, Velthuis JJ, Veltri M, Vervink K, Viaud B, Videau I, Vilasis-Cardona X, Visniakov J, Vollhardt A, Voong D, Vorobyev A, Voss H, Wacker K, Wandernoth S, Wang J, Ward DR, Webber AD, Websdale D, Whitehead M, Wiedner D, Wiggers L, Wilkinson G, Williams MP, Williams M, Wilson FF, Wishahi J, Witek M, Witzeling W, Wotton SA, Wyllie K, Xie Y, Xing F, Yang Z, Young R, Yushchenko O, Zavertyaev M, Zhang L, Zhang WC, Zhang Y, Zhelezov A, Zhong L, Zverev E, Zvyagin A. Determination of f(s)/f(d) for 7 TeV pp collisions and measurement of the B0→D-K+ branching fraction. PHYSICAL REVIEW LETTERS 2011; 107:211801. [PMID: 22181871 DOI: 10.1103/physrevlett.107.211801] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/28/2011] [Indexed: 05/31/2023]
Abstract
The relative abundance of the three decay modes B(0)→D(-)K(+), B(0)→D(-)π(+), and B(s)(0)→D(s)(-)π(+) produced in 7 TeV pp collisions at the LHC is determined from data corresponding to an integrated luminosity of 35 pb(-1). The branching fraction of B(0)→D(-)K(+) is found to be B(B(0)→D(-)K(+)) = (2.01 ± 0.18(stat) ± 0.14(syst)) × 10(-4). The ratio of fragmentation fractions f(s)/f(d) is determined through the relative abundance of B(s)(0)→D(s)(-)π(+) to B(0)→D(-)K(+) and B(0)→D(-)π(+), leading to f(s)/f(d) = 0.253 ± 0.017 ± 0.017 ± 0.020, where the uncertainties are statistical, systematic, and theoretical, respectively.
Collapse
|
57
|
Kim YM, Demissie S, Eisenberg R, Samelson EJ, Kiel DP, Bouxsein ML. Intra-and inter-reader reliability of semi-automated quantitative morphometry measurements and vertebral fracture assessment using lateral scout views from computed tomography. Osteoporos Int 2011; 22:2677-88. [PMID: 21271340 PMCID: PMC3650637 DOI: 10.1007/s00198-011-1530-4] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/10/2010] [Accepted: 12/17/2010] [Indexed: 10/18/2022]
Abstract
UNLABELLED Intra-and inter-reader reliability of semi-automated quantitative vertebral morphometry measurements was determined using lateral computed tomography (CT) scout views. The method requires less time than conventional morphometry. Reliability was excellent for vertebral height measurements, good for height ratios, and comparable to semi-quantitative grading by radiologists for identification of vertebral fractures. INTRODUCTION Underdiagnosis and undertreatment of vertebral fracture (VFx) is a well-known problem worldwide. Thus, new methods are needed to facilitate identification of VFx. This study aimed to determine intra- and inter-reader reliability of semi-automated quantitative vertebral morphometry based on shape-based statistical modeling (SpineAnalyzer, Optasia Medical, Cheadle, UK). METHODS Two non-radiologists independently assessed vertebral morphometry from CT lateral scout views at two time points in 96 subjects (50 men, 46 women, 70.3 ± 8.9 years) selected from the Framingham Heart Study Offspring and Third Generation Multi-Detector CT Study. VFxs were classified based solely on morphometry measurements using Genant's criteria. Intraclass correlation coefficients (ICCs), root mean squared coefficient of variation (RMS CV) and kappa (k) statistics were used to assess reliability. RESULTS We analyzed 1,246 vertebrae in 96 subjects. The analysis time averaged 5.4 ± 1.7 min per subject (range, 3.2-9.1 min). Intra-and inter-reader ICCs for vertebral heights were excellent (>0.95) for all vertebral levels combined. Intra-and inter-reader RMS CV for height measurements ranged from 2.5% to 3.9% and 3.3% to 4.4%, respectively. Reliability of vertebral height ratios was good to fair. Based on morphometry measurements alone, readers A and B identified 51-52 and 46-59 subjects with at least one prevalent VFx, respectively, and there was a good intra-and inter-reader agreement (k = 0.59-0.69) for VFx identification. CONCLUSIONS Semi-automated quantitative vertebral morphometry measurements from CT lateral scout views are convenient and reproducible, and may facilitate assessment of VFx.
Collapse
|
58
|
Kim YM, Yoon JU, Koh HJ. The analysis of lacquer crack in the assessment of myopic choroidal neovascularization. Eye (Lond) 2011; 25:937-46. [PMID: 21527958 DOI: 10.1038/eye.2011.94] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Abstract
OBJECTIVE The aim of this study was to clarify the characteristic findings in myopic choroidal neovascularization (CNV) and the relationship with lacquer crack (LC). METHODS In all, 66 consecutive myopic CNV patients treated with photodynamic therapy and/or intravitreal anti-vascular endothelial growth factor injection in one eye were reviewed. Data from fluorescein angiography (FA) and indocyanine green angiography (ICGA), obtained simultaneously using the Heidelberg retina angiograph 2 (HRA2), were analyzed. RESULTS LCs were associated with a relatively large extent (≥3000 μm) of peripapillary choroidal atrophy and a dark rim, the proliferation of retinal pigment epithelial cells surrounding the neovascular membrane was accompanied by a small extent. Myopic CNV usually developed in the LC area surrounded by tiny crack fragments. In all, 35 patients with LCs received FA and ICGA at least twice during follow-up. LC progression was observed in nine (25.7%) treated eyes and six (23.1%) non-CNV fellow eyes. Crack fragments progressed in three distinct forms such as elongation, branching, or bridging pattern. Newly diagnosed myopic CNV was reported in 18 treated eyes and 3 fellow eyes. Progression of LCs and development of CNV occurred simultaneously in eight eyes. By multivariate Cox's regression, a statistically significant association was observed between recurrence of myopic CNV and the absence of a dark rim on ICGA. CONCLUSIONS The HRA2 instrument affords detailed high-resolution images of FA and ICGA. Notably, recurrence of myopic CNV developed in areas surrounded by new small crack fragments and LCs are considered to be important in the development of myopic CNV.
Collapse
|
59
|
Yu M, Gang EJ, Parameswaran R, Stoddart S, Fei F, Schmidhuber S, Park E, Hsieh YT, Yang AS, Groffen J, Heisterkamp N, Kim YM. AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo. Blood Cancer J 2011; 1:e14. [PMID: 22829135 PMCID: PMC3255243 DOI: 10.1038/bcj.2011.13] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
|
60
|
Poynton MR, Choi BM, Kim YM, Park IS, Noh GJ, Hong SO, Boo YK, Kang SH. Machine learning methods applied to pharmacokinetic modelling of remifentanil in healthy volunteers: a multi-method comparison. J Int Med Res 2010; 37:1680-91. [PMID: 20146865 DOI: 10.1177/147323000903700603] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
This study compared the blood concentrations of remifentanil obtained in a previous clinical investigation with the predicted remifentanil concentrations produced by different pharmacokinetic models: a non-linear mixed effects model created by the software NONMEM; an artificial neural network (ANN) model; a support vector machine (SVM) model; and multi-method ensembles. The ensemble created from the mean of the ANN and the non-linear mixed effects model predictions achieved the smallest error and the highest correlation coefficient. The SVM model produced the highest error and the lowest correlation coefficient. Paired t-tests indicated that there was insufficient evidence that the predicted values of the ANN, SVM and two multi-method ensembles differed from the actual measured values at alpha = 0.05. The ensemble method combining the ANN and non-linear mixed effects model predictions outperformed either method alone. These results indicated a potential advantage of ensembles in improving the accuracy and reducing the variance of pharmacokinetic models.
Collapse
|
61
|
Sefah K, Tang ZW, Shangguan DH, Chen H, Lopez-Colon D, Li Y, Parekh P, Martin J, Meng L, Phillips JA, Kim YM, Tan WH. Molecular recognition of acute myeloid leukemia using aptamers. Leukemia 2009; 23:235-44. [PMID: 19151784 PMCID: PMC2640431 DOI: 10.1038/leu.2008.335] [Citation(s) in RCA: 184] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Cell surface proteins can play important roles in cancer pathogenesis. Comprehensive understanding of the surface protein expression patterns of tumor cells and, consequently, the pathogenesis of tumor cells, depends on molecular probes against these proteins. To be effectively used for tumor diagnosis, classification and therapy, such probes would be capable of specific binding to targeted tumor cells. Molecular aptamers, designer DNA/RNA probes, can address this challenge by recognizing proteins, peptides and other small molecules with high affinity and specificity. Through a process known as cell-SELEX, we used live acute myeloid leukemia (AML) cells to select a group of DNA aptamers that can recognize acute myeloid leukemia cells with dissociation constants (Kds) in the nanomolar range. Interestingly, one aptamer (KH1C12), compared with two control cell lines (K562 and NB4), showed significant selectivity to the target AML cell line (HL60) and could recognize the target cells within a complex mixture of normal bone marrow aspirates. The other two aptamers KK1B10 and KK1D04 recognize targets associated with monocytic differentiation. Our studies demonstrate that the selected aptamers can be used as a molecular tool for further understanding surface protein expression patterns on tumor cells and thus providing a foundation for effective molecular analysis of leukemia and its subcategories.
Collapse
|
62
|
Kim YM, Jung MH, Kim DY, Kim JH, Kim YT, Nam JH. Small cell carcinoma of the uterine cervix: clinicopathologic study of 20 cases in a single center. EUR J GYNAECOL ONCOL 2009; 30:539-542. [PMID: 19899411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
PURPOSE To investigate clinicopathologic findings of patients with small cell carcinoma of the uterine cervix (SCCUC), and evaluate their prognosis. METHODS We retrospectively reviewed the medical records of 20 patients with histologically confirmed SCCUC treated between October 1996 and December 2004 at Asan Medical Center, Korea. The review included demographic data, pathologic findings, treatments, and outcomes. RESULTS Of 1,358 invasive cervical carcinoma, the incidence of SCCUC was 1.5%. Median age was 45.5 years. The clinical stages were Ib in 11, IIa in two, IIb in one, IIIa in one, IIIb in one, IVa in three and IVb in one. Fourteen patients underwent radical hysterectomy. Ten patients are alive and nine show no evidence of disease. Median overall survival was 77.0 months and 5-year overall survival rate was 50%. There was significant difference in overall survival with FIGO stage and tumor mass size. CONCLUSION Advanced FIGO stage and tumor mass size are poor prognostic factors for overall survival in patients with SCCUC. Even though SCCUC is a highly aggressive neoplasm, early diagnosis and combined therapeutic modalities may lead to longer survival in some patients.
Collapse
|
63
|
Choi SP, Park HK, Park KN, Kim YM, Ahn KJ, Choi KH, Lee WJ, Jeong SK. The density ratio of grey to white matter on computed tomography as an early predictor of vegetative state or death after cardiac arrest. Emerg Med J 2008; 25:666-9. [DOI: 10.1136/emj.2007.053306] [Citation(s) in RCA: 105] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
64
|
Fallert SV, Kim YM, Neugebauer CJ, Taraskin SN. Contact process in disordered and periodic binary two-dimensional lattices. PHYSICAL REVIEW. E, STATISTICAL, NONLINEAR, AND SOFT MATTER PHYSICS 2008; 78:041117. [PMID: 18999389 DOI: 10.1103/physreve.78.041117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/04/2008] [Revised: 08/28/2008] [Indexed: 05/27/2023]
Abstract
The critical behavior of the contact process (CP) in disordered and periodic binary two-dimensional (2D) lattices is investigated numerically by means of Monte Carlo simulations as well as via an analytical approximation and standard mean field theory. Phase-separation lines calculated numerically are found to agree well with analytical predictions around the homogeneous point. For the disordered case, values of static scaling exponents obtained via quasistationary simulations are found to change with disorder strength. In particular, the finite-size scaling exponent of the density of infected sites approaches a value consistent with the existence of an infinite-randomness fixed point as conjectured before for the 2D disordered CP. At the same time, both dynamical and static scaling exponents are found to coincide with the values established for the homogeneous case thus confirming that the contact process in a heterogeneous environment belongs to the directed percolation universality class.
Collapse
|
65
|
Kim HJ, Kim YM, Lim S, Nam YK, Jeong J, Kim HJ, Lee KJ. Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis. Oncogene 2008; 28:117-27. [DOI: 10.1038/onc.2008.364] [Citation(s) in RCA: 113] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
66
|
Lee HJ, Lee GH, Nah S, Lee KH, Yang H, Kim YM, Chun W, Hong S, Kim S. Association of TIMP-4 gene polymorphism with the risk of osteoarthritis in the Korean population. Rheumatol Int 2008; 28:845-50. [PMID: 18301898 DOI: 10.1007/s00296-008-0545-4] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2007] [Accepted: 02/11/2008] [Indexed: 01/29/2023]
Abstract
Due to an imbalance in the MMP:TIMP ratio determined a tissue damage in arthritis, it is hypothesized that polymorphic variations of the TIMP genes are associated with regulation of the MMP:TIMP balance. To test this hypothesis, the presence of single nucleotide polymorphisms (SNPs) located in the human TIMP-2 and TIMP-4 genes was confirmed in the Korean RA and OA patients. We performed a case-control study comprising 109 unrelated Korean OA patients, 177 unrelated Korean RA patients and 175 healthy subjects. There were statistically significant differences in the genotype distribution and allele frequencies of the C/T polymorphism of TIMP-4 gene between OA and control groups (P = 0.0002 and P = 0.001, respectively). However, no significant association between TIMP-2 polymorphisms and OA was observed. Also, no difference was observed when allele or genotype frequencies of both TIMP-2 and TIMP-4 gene polymorphisms were compared between RA and controls. We demonstrated that the C/T polymorphism which is located on the 3'-untranslational regions of the TIMP-4 gene might be associated with susceptibility to OA patients.
Collapse
|
67
|
Ahn CK, Kim YM, Woo SH, Park JM. Soil washing using various nonionic surfactants and their recovery by selective adsorption with activated carbon. JOURNAL OF HAZARDOUS MATERIALS 2008; 154:153-160. [PMID: 18006231 DOI: 10.1016/j.jhazmat.2007.10.006] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/27/2007] [Revised: 10/03/2007] [Accepted: 10/03/2007] [Indexed: 05/25/2023]
Abstract
The performance of activated carbon in soil washing and subsequent selective adsorption for surfactant recovery from the washed solution was investigated. Sandy loam soil contaminated with phenanthrene at 200 mg kg(-1) was washed with four different nonionic surfactants: Tween 40, Tween 80, Brij 30 and Brij 35. The efficiency of soil washing was highest when using Brij 30 with the highest solubilizing ability for phenanthrene and low adsorption onto soil. In the selective adsorption step, surfactant recovery was quite effective for all surfactants ranging from 85.0 to 89.0% at 1 g L(-1) of activated carbon (Darco 20-40 mesh). Phenanthrene removal from the solution washed with Brij 30 was only 33.9%, even though it was 54.1-56.4% with other surfactants. The selectivity was larger than 7.02 except for Brij 30 (3.60). The overall performance considering both the washing and surfactant recovery step was effective when using Tween 80 and Brij 35. The results suggest that higher solubilizing ability of surfactants is a requirement for soil washing but causes negative effects on phenanthrene removal in the selective adsorption. Therefore, if a surfactant recovery process by selective adsorption is included in soil remediation by washing, the overall performance including the two steps should be considered for properly choosing the surfactant.
Collapse
|
68
|
Kim CS, Lee SC, Kim YM, Kim BS, Choi HS, Kawada T, Kwon BS, Yu R. Visceral fat accumulation induced by a high-fat diet causes the atrophy of mesenteric lymph nodes in obese mice. Obesity (Silver Spring) 2008; 16:1261-9. [PMID: 18369345 DOI: 10.1038/oby.2008.55] [Citation(s) in RCA: 53] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
OBJECTIVE A high intake of fat in the diet plays a crucial role in promoting obesity and obesity-related pathologies, and especially visceral obesity is closely associated with obesity-related complications. Because adipose tissue is anatomically associated with lymph nodes, the secondary lymphoid organ, we hypothesized that fat tissue-derived factors may influence the cellularity of lymphoid tissue embedded in fat. METHODS AND PROCEDURES Mesenteric and inguinal lymph nodes were isolated from obese mice fed a high-fat diet and control mice fed a regular diet. T-cell population, activation state, and the extent of apoptosis were determined by flow cytometric analysis or terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL) assay. RESULTS The weight of mesenteric lymph nodes and the total number of lymphoid cells in the obese mice significantly decreased compared with those in the control mice; however, no change was observed in the weight of inguinal lymph nodes. The numbers of CD4(+) and CD8(+) T cells in the mesenteric lymph nodes of obese mice significantly decreased compared with those of the control. Enhanced T-cell activation and apoptosis were observed in the mesenteric lymph node cells of the obese mice. The treatment of lymph node cells with free fatty acids, oxidative stress, and chylomicrons, which are obesity-related factors, resulted in lymph node T-cell activation and apoptosis. DISCUSSION These results suggest that visceral fat accumulation with a high-fat diet can cause the atrophy of mesenteric lymph nodes by enhancing activation-induced lymphoid cell apoptosis. Dietary fat-induced visceral obesity may be crucial for obesity-related immune dysfunction.
Collapse
|
69
|
Kim JS, Romero R, Kim MR, Kim YM, Friel L, Espinoza J, Kim CJ. Involvement of Hofbauer cells and maternal T cells in villitis of unknown aetiology. Histopathology 2008; 52:457-64. [PMID: 18315598 DOI: 10.1111/j.1365-2559.2008.02964.x] [Citation(s) in RCA: 118] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
AIMS The nature of villitis of unknown aetiology (VUE) is intriguing in terms of its aetiology, origin of inflammatory cells and immunophenotype of T cells involved. The aim was to determine the origin of macrophages and the immunophenotype of T lymphocytes in VUE associated with various complications of pregnancy. METHODS AND RESULTS Placentas with VUE (n = 45) were studied by chromogenic in-situ hybridization (CISH) for Y chromosome (DYZ1) and immunohistochemistry for CD14, CD68, Ki67 (n = 10; all from male neonates) and a panel of T-cell antigens (CD3, CD4 and CD8) (n = 35). All of the placentas from male neonates showed CISH+ signals from Y chromosomes in the majority of macrophages, but not in lymphocytes, indicating that the macrophages were of fetal origin. Many macrophages of the affected chorionic villi were Ki67+, suggesting that they are hyperplastic Hofbauer cells. Among the lymphocytes, CD8+ T cells outnumbered CD4+ T cells in all placentas with different obstetrical conditions. CONCLUSIONS We define primary components of VUE as maternal CD8+ T cells and hyperplastic Hofbauer cells. We propose that VUE is a unique inflammatory reaction where the leucocytes from two hosts are key partners, analogous to either allograft rejection or graft-versus-host disease.
Collapse
|
70
|
Stubbs MC, Kim YM, Krivtsov AV, Wright RD, Feng Z, Agarwal J, Kung AL, Armstrong SA. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment. Leukemia 2007; 22:66-77. [PMID: 17851551 PMCID: PMC2936245 DOI: 10.1038/sj.leu.2404951] [Citation(s) in RCA: 92] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Human leukemias harboring chromosomal translocations involving the mixed lineage leukemia (MLL, HRX, ALL-1) gene possess high-level expression, and frequent activating mutations of the receptor tyrosine kinase FLT3. We used a murine bone marrow transplant model to assess cooperation between MLL translocation and FLT3 activation. We demonstrate that MLL-AF9 expression induces acute myelogenous leukemia (AML) in approximately 70 days, whereas the combination of MLL-AF9 and FLT3-ITD does so in less than 30 days. Secondary transplantation of splenic cells from diseased mice established that leukemia stem cells are present at a very high frequency of approximately 1:100 in both diseases. Importantly, prospectively isolated granulocyte macrophage progenitors (GMPs) coinfected with MLL-AF9 and FLT3-ITD give rise to a similar AML, with shorter latency than from GMP transduced with MLL-AF9 alone. Cooperation between MLL-AF9 and FLT3-ITD was further verified by real-time assessment of leukemogenesis using noninvasive bioluminescence imaging. We used this model to demonstrate that MLL-AF9/FLT3-ITD-induced leukemias are sensitive to FLT3 inhibition in a 2-3 week in vivo assay. These data show that activated FLT3 cooperates with MLL-AF9 to accelerate onset of an AML from whole bone marrow as well as a committed hematopoietic progenitor, and provide a new genetically defined model system that should prove useful for rapid assessment of potential therapeutics in vivo.
Collapse
MESH Headings
- Animals
- Blotting, Southern
- Blotting, Western
- Bone Marrow Transplantation
- Cell Proliferation
- Disease Models, Animal
- Female
- Granulocytes/cytology
- Hematopoietic Stem Cells/cytology
- Hematopoietic Stem Cells/metabolism
- Humans
- Immunophenotyping
- Immunoprecipitation
- Leukemia, Myeloid, Acute/etiology
- Leukemia, Myeloid, Acute/pathology
- Luciferases/metabolism
- Macrophages/cytology
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Mutation
- Myeloid-Lymphoid Leukemia Protein/genetics
- Myeloid-Lymphoid Leukemia Protein/metabolism
- Oncogene Proteins, Fusion/genetics
- Oncogene Proteins, Fusion/metabolism
- Promoter Regions, Genetic
- Reverse Transcriptase Polymerase Chain Reaction
- Tandem Repeat Sequences
- Transfection
- Tumor Cells, Cultured
- fms-Like Tyrosine Kinase 3/genetics
- fms-Like Tyrosine Kinase 3/metabolism
Collapse
|
71
|
Kim JS, Romero R, Cushenberry E, Kim YM, Erez O, Nien JK, Yoon BH, Espinoza J, Kim CJ. Distribution of CD14+ and CD68+ Macrophages in the Placental Bed and Basal Plate of Women With Preeclampsia and Preterm Labor. Placenta 2007; 28:571-6. [PMID: 17052752 DOI: 10.1016/j.placenta.2006.07.007] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/19/2006] [Revised: 07/25/2006] [Accepted: 07/26/2006] [Indexed: 12/26/2022]
Abstract
OBJECTIVE Macrophages play a key role in implantation, placentation and parturition. Yet, whether or not the number of macrophages at the fetomaternal interface (basal plate of the placenta and placental bed) is altered in women with preeclampsia is the subject of controversy. The purpose of this study was to compare the immunoreactivity and distribution patterns of CD14 and CD68 positive macrophages in both the basal plate and placental bed from preeclamptic and non-preeclamptic pregnancies. METHODS A cross-sectional study was conducted. Paraffin embedded sections of placental tissues and placental bed biopsies were obtained from patients with early onset preeclampsia (n=10) and from those with preterm labor/delivery (n=10) without preeclampsia matched for gestational age. Double immunohistochemistry using antibodies to CD14 and CD68 was performed, and the density of double or single positive cells in the basal plate and placental bed was evaluated. Non-parametric statistics were used for analysis. RESULTS 1) A unique subset of CD14-/CD68+ cells was identified. The cells in question were present at a higher level in the decidua than in the myometrial segment of the placental bed (p<0.01); 2) The density and proportion of CD14+/CD68+ cells (double positive cells) were significantly higher in the myometrial segment than in the basal plate (p=0.0003); and 3) There were no significant differences in the density and patterns of immunopositive macrophages in the basal plate, the decidua, and the myometrium between women with preeclampsia and those with preterm labor/delivery (p>0.05). CONCLUSION The macrophages at the fetomaternal interface can be dichotomized by CD14 and CD68 immunoreactivity. A gradient of CD14+/CD68+ macrophages was demonstrated between the superficial myometrium and the basal plate regardless of the etiology of preterm birth (preeclampsia or spontaneous preterm labor). The biological function of single positive (CD14-/CD68+) and double positive (CD14+/CD68+) macrophages at the fetomaternal interface remains to be established. The overall findings also suggest that the discrepancies in the literature are due to the varying markers used to detect macrophages and in the anatomical plane of the fetomaternal junction analyzed.
Collapse
|
72
|
Han YM, Romero R, Kim YM, Kim JS, Richani K, Friel LA, Kusanovic JP, Jeanty C, Vitale S, Nien JK, Espinoza J, Kim CJ. Surfactant protein-A mRNA expression by human fetal membranes is increased in histological chorioamnionitis but not in spontaneous labour at term. J Pathol 2007; 211:489-96. [PMID: 17273989 DOI: 10.1002/path.2131] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Surfactant protein-A (SP-A) is produced by the fetal lung, participates in innate immunity, and has been proposed to play a role in the initiation of parturition in mice. Amniotic fluid SP-A concentration increases as a function of gestational age, and SP-A protein has been demonstrated in human chorioamniotic membranes. This study was conducted to determine whether parturition at term, gestational age and chorioamnionitis in preterm delivery (PTD) are associated with changes in the expression of SP-A in the chorioamniotic membranes. Chorioamniotic membranes were obtained from women at term and women with PTD (n=58). SP-A mRNA and protein expression was detected in amniotic epithelial cells, chorionic trophoblasts and macrophages by in situ hybridization and immunohistochemistry. Quantitative real-time reverse transcription-PCR demonstrated predominant expression of SP-A1 mRNA, whose expression was 17.4-fold higher in patients with PTD with chorioamnionitis (n=15) than in those without (n=13) (p=0.018). While no difference was observed in SP-A1 mRNA expression in the chorioamniotic membranes of women at term not in labour (n=16) and those in labour (n=14) (p=0.87), the expression in term membranes was higher than that of membranes from women with PTD without chorioamnionitis (p=0.003). Analysis of JAR choriocarcinoma cells demonstrated SP-A1 mRNA expression that was up-regulated following lipopolysaccharide treatment. Furthermore, monocytic cell lines (THP-1 and U937) and peripheral blood monocytes (CD14+/CD115+) obtained from pregnant women also expressed SP-A1 mRNA and protein, suggesting the presence of autocrine/paracrine activation in vivo. Interestingly, a mid-trimester amniotic fluid sample obtained from a case of tracheal atresia contained SP-A (3.13 microg/ml), indicating the presence of SP-A of extrapulmonary origin. These findings suggest not only that SP-A expression is a part of the innate immune response deployed during chorioamniotic inflammation, but also that chorioamniotic membranes are a source of SP-A in the amniotic fluid with advancing gestation.
Collapse
|
73
|
Kim YM, Romero R, Chaiworapongsa T, Espinoza J, Mor G, Kim CJ. Dermatitis as a component of the fetal inflammatory response syndrome is associated with activation of Toll-like receptors in epidermal keratinocytes. Histopathology 2006; 49:506-14. [PMID: 17064297 PMCID: PMC1804207 DOI: 10.1111/j.1365-2559.2006.02542.x] [Citation(s) in RCA: 73] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Aims Microbial invasion of the amniotic cavity (MIAC) elicits a fetal inflammatory response such as funisitis and chorionic vasculitis. However, little is known about the changes of fetal skin during MIAC. Toll-like receptors recognize microbial products and initiate an immune response. The aims of this study were to examine histopathological features of fetal skin exposed to MIAC and to assess the changes in Toll-like receptor (TLR)-2 and TLR-4 expression. Methods and results Skin samples were obtained from fetal autopsies (n = 12). The cases were classified according to the presence (n = 8) or absence (n = 4) of acute chorioamnionitis and analysed by immunohistochemistry using a panel of antibodies. Leucocytic infiltrates into the superficial dermis were observed in cases with chorioamnionitis; the majority of inflammatory cells were neutrophils, lymphocytes and histiocytes. TLR-2 immunoreactivity in the skin was stronger in fetuses with chorioamnionitis than in those without this condition. However, immunoreactivity of TLR-4 in the fetal skin was constitutively expressed, regardless of the presence or absence of chorioamnionitis. Conclusions This study demonstrates for the first time that fetal dermatitis can be detected and is part of the fetal inflammatory response syndrome (FIRS). We propose that this ‘FIRS-associated fetal dermatitis’ is a fetal counterpart of chorioamnionitis.
Collapse
|
74
|
Rhee KJ, Kim KC, Lee JK, Hwang DS, Shin HD, Yang JY, Kim YM. Incomplete discoid glenoid labrum combined with a ganglion cyst of the spinoglenoid notch. ACTA ACUST UNITED AC 2006; 88:1390-2. [PMID: 17012434 DOI: 10.1302/0301-620x.88b10.18027] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
In a 41-year-old man, right-sided infraspinatus muscle weakness was associated with compression of the suprascapular nerve caused by a spinoglenoid ganglion cyst. The lesion was confirmed using electromyography and MRI. In addition, arthroscopy showed an incomplete discoid labrum. The free inner edge of the labrum was removed as in a meniscectomy of a discoid meniscus in the knee joint. Arthroscopic decompression of the cyst was performed through a juxtaglenoid capsulotomy which was left open. Neurological function recovered completely.
Collapse
|
75
|
Nam JH, Kim YM, Jung MH, Kim KR, Yoo HJ, Kim DY, Kim JH, Kim YT, Mok JE. Primary peritoneal carcinoma: experience with cytoreductive surgery and combination chemotherapy. Int J Gynecol Cancer 2006; 16:23-8. [PMID: 16445605 DOI: 10.1111/j.1525-1438.2006.00314.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
The objective of this study was to review the clinical outcome and prognosis of patients with primary peritoneal carcinoma (PPC) treated with cytoreductive surgery and combination chemotherapy. We retrospectively reviewed the charts of 27 patients with histologically confirmed PPC, treated between March 1990 and February 2004 at Asan Medical Center, South Korea. The review included demographic data, pathologic findings, treatments, and outcomes. The mean age of the 27 patients was 57.5 +/- 7.2 years, and the rate of optimal cytoreduction was 70.4%. Seven patients had stage IIIB, 17 had stage IIIC, and 3 had stage IV; all patients received adjuvant chemotherapy. There were 4 patients with progressive disease, 5 partial responders, and 15 complete responders; the remaining 3 patients were nonevaluable. At the time of the review, 10 patients were alive without evidence of disease, 3 were alive with disease, and 14 had died from disease. The median overall survival time was 41 months, and the overall 5-year survival rate was 18.1%. Patients who had optimal cytoreduction had a longer median survival (42 months) than those who had suboptimal cytoreduction (10 months; P < 0.05). Combination chemotherapy after optimal cytoreductive surgery may be effective in the treatment of patients with PPC.
Collapse
|